PUBLISHER: GlobalData | PRODUCT CODE: 1494265
PUBLISHER: GlobalData | PRODUCT CODE: 1494265
Inferior Vena Cava Filters (IVCF) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on the Inferior Vena Cava Filters market for the year 2020 and beyond. An inferior Vena Cava Filter (IVCF) is a type of vascular filter used to prevent blood clots from traveling to the lungs.
The filter is inserted inside a large vein called the inferior vena cava (which carries blood from the lower extremities to the heart). IVC filter traps blood clots before it reaches the lungs. It is commonly used as a preventive measure in cases where DVT and PE have been diagnosed or as a prophylactic device in cases where the risk of developing VTE is high and there is a contraindication for anticoagulants.
The usage of IVC filters can prevent PE, but it does not restrict blood clot formation. IVC filters are made of non-ferromagnetic materials [Cobalt Chromium Alloy, Stainless Steel, Titanium, Nickel-Titanium (Nitinol)]. Permanent and retrievable IVC filters have been tracked under this segment.
Each of the covered 39 country's color-coded and fully-sourced market models is equipped with epidemiology-based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers the installed base, new sales volumes, product usage, average selling prices, market size, and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Inferior Vena Cava Filters (IVCF) and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Mermaid Medical A/S, Becton Dickinson and Co, Argon Medical Devices Inc, Cook Group Inc, Cardinal Health Inc, B. Braun Melsungen AG, LifeTech Scientific Corp, Merit Medical Systems Inc, ALN implants chirurgicaux, Boston Scientific Corp, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -